"With Chan taking multiple drugs, chemo, steroids, etc .....If he is cured or survives, God willing, an unprecedented length of time...will LL get credited with being the one?"

I am sure that answer will be no. However, if he beats the cancer, I am sure that he will need to take Leronlimab for a long time afterwards (quite likely for the rest of his life). If the cancer doesn't return, we may see a paper on Leronlimab's contribution. I guess that would depend on how detailed the information is, that is recorded and given to the company. There are a lot of ifs. I bet his Oncologist writes a paper and brings in CYDY to coauthor.

Investors Hangout: https://investorshangout.com/post/view?id=672...z8qMQKpuMv